1 Center for Research on Rare Blood Disorders (CR-RBD), Burjeel Medical City, Abu Dhabi, United Arab Emirates.
2 S.C. Centro delle Microcitemie e Anemie Rare, ASL Cagliari, Cagliari, Italy.
3 Università di Cagliari, S.C. Centro delle Microcitemie e Anemie Rare, ASL Cagliari, Cagliari, Italy.
4 Hemoglobinopathies Reference Center, San Luigi Gonzaga Teaching Hospital, Department of Biological and Clinical Sciences, University of Turin, Turin, Italy.
5 Thalassemia Unit, ARNAS Garibaldi, Catania, Italy.
6 Centro della Microcitemia A.Quarta, Hematology Unit, A. Perrino Hospital, Brindisi, Italy.
7 Day Hospital della Talassemia e delle Emoglobinopatie, Azienda Ospedaliero Universitaria S. Anna, Ferrara, Italy.
Rate and risk factors for phenoconversion from non-transfusion-dependent β-thalassemia (NTDT) to transfusion-dependent β-thalassemia (TDT) during a 10-year follow up of adult patients in Italy.